Methylene blue improves brain oxidative metabolism and memory retention in rats

被引:103
作者
Callaway, NL
Riha, PD
Bruchey, AK
Munshi, Z
Gonzalez-Lima, F
机构
[1] Univ Texas, Dept Psychol, Austin, TX 78712 USA
[2] Univ Texas, Dept Neurosci, Austin, TX 78712 USA
[3] Univ Texas, Dept Pharmacol, Austin, TX 78712 USA
关键词
cytochrome oxidase; methylene blue; mitochondria; oxygen consumption; holeboard maze; memory retention; spatial memory; cerebral metabolism; neurodegenerative diseases;
D O I
10.1016/j.pbb.2003.10.007
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Methylene blue (MB) increases mitochondrial oxygen consumption and restores memory retention in rats metabolically impaired by inhibition of cytochrome c oxidase. This study tested two related hypotheses using biochemical and behavioral techniques: (1) that low-level NIB would enhance brain cytochrome c oxidation, as tested in vitro in brain homogenates and after in vivo administration to rats and (2) that corresponding low-dose MB would enhance spatial memory retention in normal rats, as tested 24 It after rats were trained in a baited holeboard maze for 5 days with daily MB posttraining injections. The biochemical in vitro studies showed an increased rate of brain cytochrome c oxidation with the low but not the high MB concentrations tested. The in vivo administration studies showed that the corresponding MB low dose (1 mg/kg) increased brain cytochrome c oxidation 24 h after intraperitoneal injection, but not after I or 2 h postinjection. In the behavioral studies, spatial memory retention in probe trials (percentage of visits to training-baited holes compared to total visits) was significantly better for MB-treated than saline control groups (66% vs. 3 1 %). Together the findings suggest that low-dose MB enhances spatial memory retention in normal rats by increasing brain cytochrome c oxidase activity. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:175 / 181
页数:7
相关论文
共 21 条
[1]   DO DEFECTS IN MITOCHONDRIAL ENERGY-METABOLISM UNDERLIE THE PATHOLOGY OF NEURODEGENERATIVE DISEASES [J].
BEAL, MF ;
HYMAN, BT ;
KOROSHETZ, W .
TRENDS IN NEUROSCIENCES, 1993, 16 (04) :125-131
[2]   Synergy between chronic corticosterone and sodium azide treatments in producing a spatial learning deficit and inhibiting cytochrome oxidase activity [J].
Bennett, MC ;
Mlady, GW ;
Fleshner, M ;
Rose, GM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (03) :1330-1334
[3]   CHRONIC SODIUM-AZIDE TREATMENT IMPAIRS LEARNING OF THE MORRIS WATER MAZE TASK [J].
BENNETT, MC ;
ROSE, GM .
BEHAVIORAL AND NEURAL BIOLOGY, 1992, 58 (01) :72-75
[4]   BIOENERGETIC AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISEASES [J].
BOWLING, AC ;
BEAL, MF .
LIFE SCIENCES, 1995, 56 (14) :1151-1171
[5]   METHYLENE-BLUE - EFFECTS AND DISPOSITION IN SHEEP [J].
BURROWS, GE .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1984, 7 (03) :225-231
[6]   Regional brain effects of sodium azide treatment on cytochrome oxidase activity: A quantitative histochemical study [J].
Cada, A ;
GonzalezLima, F ;
Rose, GM ;
Bennett, MC .
METABOLIC BRAIN DISEASE, 1995, 10 (04) :303-320
[7]   PATHOGENIC FACTORS UNDERLYING THE LESIONS IN LEIGHS DISEASE - TISSUE RESPONSES TO CELLULAR-ENERGY DEPRIVATION AND THEIR CLINICOPATHOLOGICAL CONSEQUENCES [J].
CAVANAGH, JB ;
HARDING, BN .
BRAIN, 1994, 117 :1357-1376
[8]   PHARMACOKINETICS OF HIGHLY IONIZED DRUGS .1. METHYLENE-BLUE - WHOLE-BLOOD, URINE, AND TISSUE ASSAYS [J].
DISANTO, AR ;
WAGNER, JG .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (04) :598-&
[9]  
Gonzalez-Lima F, 1998, CYTOCHROME OXIDASE IN NEURONAL METABOLISM AND ALZHEIMER'S DISEASE, P55
[10]   Quantitative cytochemistry of cytochrome oxidase and cellular morphometry of the human inferior colliculus in control and Alzheimer's patients [J].
GonzalezLima, F ;
Valla, J ;
MatosCollazo, S .
BRAIN RESEARCH, 1997, 752 (1-2) :117-126